| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161477836P | 2011-04-21 | 2011-04-21 | |
| PCT/US2012/034456WO2012145630A2 (en) | 2011-04-21 | 2012-04-20 | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria |
| Publication Number | Publication Date |
|---|---|
| MX2013012241A MX2013012241A (en) | 2014-05-07 |
| MX336427Btrue MX336427B (en) | 2016-01-18 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013012241AMX336427B (en) | 2011-04-21 | 2012-04-20 | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria. |
| MX2016000588AMX370442B (en) | 2011-04-21 | 2012-04-20 | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria. |
| MX2019015029AMX383544B (en) | 2011-04-21 | 2012-04-20 | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria |
| MX2021007008AMX2021007008A (en) | 2011-04-21 | 2013-10-18 | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria. |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016000588AMX370442B (en) | 2011-04-21 | 2012-04-20 | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria. |
| MX2019015029AMX383544B (en) | 2011-04-21 | 2012-04-20 | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria |
| MX2021007008AMX2021007008A (en) | 2011-04-21 | 2013-10-18 | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria. |
| Country | Link |
|---|---|
| US (7) | US9034322B2 (en) |
| EP (2) | EP2699253B1 (en) |
| JP (4) | JP6139509B2 (en) |
| CN (4) | CN115887627A (en) |
| AU (3) | AU2012245357B2 (en) |
| CA (1) | CA2833409A1 (en) |
| DK (1) | DK2699253T3 (en) |
| ES (1) | ES2682670T3 (en) |
| HK (2) | HK1244503A1 (en) |
| IL (4) | IL228869B (en) |
| MX (4) | MX336427B (en) |
| WO (1) | WO2012145630A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3604339T (en) | 2011-01-14 | 2021-04-13 | Univ California | Therapeutic antibodies against ror-1 protein and methods for use of same |
| JP2014519485A (en)* | 2011-04-21 | 2014-08-14 | ユニベルシタイト ユトレヒト ホールディング ベーフェー | Streptococcus bacteriophage lysine for treating gram positive bacteria in companion animals and livestock |
| NL2007038C2 (en)* | 2011-07-04 | 2013-01-07 | Vereniging Voor Christelijk Hoger Onderwijs | System and method for predicting the viability of a body tissue in a patient, and measuring device used therein. |
| CA2872902A1 (en)* | 2012-05-09 | 2013-11-14 | Contrafect Corporation | Bacteriophage lysin and antibiotic combinations against gram positive bacteria |
| RU2646102C2 (en)* | 2012-05-09 | 2018-03-01 | Контрафект Корпорейшн | Biofilm prevention, destruction and treatment by bacteriophage lysin |
| CN104073478A (en)* | 2014-06-13 | 2014-10-01 | 上海交通大学 | Enzymatic antibiotic for killing gram-positive bacteria and preparation and use of enzymatic antibiotic |
| AU2015279705B2 (en) | 2014-06-26 | 2021-04-01 | The Rockefeller University | Acinetobacter lysins |
| CN104726439B (en)* | 2015-04-13 | 2017-11-14 | 武汉菲吉乐科生物科技有限公司 | A kind of streptococcus lyases of wide spectrum and its application |
| CN104805066B (en)* | 2015-05-18 | 2018-04-24 | 武汉菲吉乐科生物科技有限公司 | A kind of staphylolytic enzyme and its application |
| WO2017023680A1 (en)* | 2015-07-31 | 2017-02-09 | The Regents Of The University Of California | Mycobacterium lysterase: a novel treatment for acne |
| EP3341013A4 (en)* | 2015-09-13 | 2018-07-18 | The Rockefeller University | Clostridium difficile BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF Clostridium difficile BACTERIA INFECTION |
| KR20180052754A (en) | 2015-09-17 | 2018-05-18 | 콘트라펙트 코포레이션 | Use of lysine to restore / enhance antimicrobial activity of antibiotics inhibited in the presence of pulmonary surfactant |
| JP6875756B2 (en) | 2016-05-12 | 2021-05-26 | コントラフェクト コーポレイション | Microliquid dilution method for assessing and determining the minimum inhibitory concentration of antibacterial polypeptides |
| US20220023399A1 (en)* | 2017-07-10 | 2022-01-27 | Contrafect Corporation | Blood component potentiation of lytic protein anti-bacterial activity and methods and uses thereof |
| JP2021506769A (en) | 2017-12-12 | 2021-02-22 | コントラフェクト コーポレイション | Identification of lysins and their derivatives that have bactericidal activity against Pseudomonas aeruginosa |
| KR20250103784A (en)* | 2018-01-05 | 2025-07-07 | 아지트라 인코포레이티드 | Auxotrophic strains of staphylococcus bacterium |
| CA3092109A1 (en)* | 2018-02-26 | 2019-08-29 | Contrafect Corporation | Modified plyss2 lysins and uses thereof |
| KR102073086B1 (en)* | 2018-06-04 | 2020-02-04 | (주)인트론바이오테크놀로지 | Novel Streptococcus suis bacteriophage Str-SUP-1 and its use for preventing proliferation of Streptococcus suis |
| KR102073088B1 (en)* | 2018-06-04 | 2020-02-04 | (주)인트론바이오테크놀로지 | Novel Streptococcus suis bacteriophage Str-SUP-2 and its use for preventing proliferation of Streptococcus suis |
| KR102073094B1 (en)* | 2018-06-04 | 2020-02-04 | (주)인트론바이오테크놀로지 | Novel Streptococcus suis bacteriophage Str-SUP-3 and its use for preventing proliferation of Streptococcus suis |
| WO2020037031A1 (en)* | 2018-08-17 | 2020-02-20 | Becton, Dickinson And Company | Antimicrobial susceptibility testing using microdroplets |
| WO2020077286A1 (en) | 2018-10-12 | 2020-04-16 | Quidel Corporation | Extraction reagent for use in an assay for detection of group a streptococcus |
| CA3134154A1 (en)* | 2019-03-22 | 2020-10-01 | Contrafect Corporation | Method of treating infective endocarditis |
| BR112021019430A2 (en)* | 2019-04-05 | 2021-11-30 | Contrafect Corp | Lysins and their derivatives with bactericidal activity against pseudomonas aeruginosa, in the presence of human serum |
| EP3980049A4 (en)* | 2019-04-11 | 2023-07-19 | Contrafect Corporation | Method of treating and preventing bone and joint infections |
| WO2021236636A1 (en)* | 2020-05-19 | 2021-11-25 | Contrafect Corporation | MODIFIED PlySs2 LYSINS AND ANTIBIOTIC COMBINATIONS FOR USE AGAINST GRAM-POSITIVE BACTERIA |
| US20220087266A1 (en)* | 2020-09-22 | 2022-03-24 | Mars, Incorporated | Compositions and methods for controlling mycotoxin production |
| CN114480299B (en)* | 2020-10-27 | 2023-08-29 | 暨南大学 | A kind of bacillus cereus phage and its application |
| CN112760312B (en)* | 2021-01-20 | 2022-06-17 | 华中农业大学 | Lyase plysX 609 for cracking gram-positive bacteria and application thereof |
| WO2023049747A1 (en)* | 2021-09-22 | 2023-03-30 | Elanco Us Inc. | Streptococcus suis lytic enzyme compositions and methods of use thereof |
| KR102742550B1 (en)* | 2022-07-26 | 2024-12-18 | 주식회사 인트론바이오테크놀로지 | Antibacterial Protein Having Lytic Activity to Streptococci |
| WO2024059184A1 (en)* | 2022-09-16 | 2024-03-21 | The Johns Hopkins University | Machine learning systems and related aspects for the detection of disease states |
| CN116640754B (en)* | 2023-07-21 | 2023-10-10 | 临沂大学 | A kind of Streptococcus prophage lytic enzyme lys224 and its application |
| CN117866985B (en)* | 2023-10-11 | 2024-08-30 | 圆因(北京)生物科技有限公司 | RNA sequence for expressing methicillin-resistant staphylococcus aureus endolysin |
| CN118272361A (en)* | 2024-05-13 | 2024-07-02 | 内蒙古农业大学 | A fermented mucus lactobacillus phage lytic enzyme LysLFP01 and its preparation method and application |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3278378A (en) | 1962-04-19 | 1966-10-11 | Schindler Charles Alvin | Staphylococcus-derived antibiotic |
| US3398056A (en) | 1964-07-10 | 1968-08-20 | Mead Johnson & Co | Process for producing lysostaphin by fermentation |
| US3594284A (en) | 1968-06-04 | 1971-07-20 | Mead Johnson & Co | Lysostaphin fermentation with accelerated time cycle |
| US3654090A (en) | 1968-09-24 | 1972-04-04 | Organon | Method for the determination of antigens and antibodies |
| NL154598B (en) | 1970-11-10 | 1977-09-15 | Organon Nv | PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING. |
| US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
| NZ201918A (en) | 1981-09-18 | 1987-04-30 | Genentech Inc | N-terminal methionyl analogues of bovine growth hormone |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| EP0163696B1 (en) | 1983-11-14 | 1992-11-25 | Columbia Laboratories, Inc. | Use of a bioadhesive |
| CH0229046H1 (en) | 1985-03-30 | 1998-07-15 | Stuart Alan Kauffman | METHOD FOR OBTAINING DNA, RNA, PEPTIDES, POLYPEPTINIQUE. DES OR PROTEINS BY MEANS OF A DNA RECOMBINANT TECH |
| WO1988002781A1 (en) | 1986-10-08 | 1988-04-21 | David Bernstein | Method for exposing group a streptococcal antigens and an improved diagnostic test for the identification of group a streptococci |
| US4948580A (en) | 1988-12-08 | 1990-08-14 | E. R. Squibb & Sons, Inc. | Muco-bioadhesive composition |
| JPH02258718A (en) | 1989-03-31 | 1990-10-19 | Nippon Kayaku Co Ltd | Pasty base and pharmaceutical |
| US5264563A (en) | 1990-08-24 | 1993-11-23 | Ixsys Inc. | Process for synthesizing oligonucleotides with random codons |
| AU690528B2 (en) | 1992-12-04 | 1998-04-30 | Medical Research Council | Multivalent and multispecific binding proteins, their manufacture and use |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5554380A (en) | 1994-08-04 | 1996-09-10 | Kv Pharmaceutical Company | Bioadhesive pharmaceutical delivery system |
| US5863560A (en) | 1996-09-11 | 1999-01-26 | Virotex Corporation | Compositions and methods for topical application of therapeutic agents |
| US5942243A (en) | 1996-11-12 | 1999-08-24 | Polytherapeutics, Inc. | Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| US5997862A (en) | 1997-10-31 | 1999-12-07 | New Horizons Diagnostics Corporation | Therapeutic treatment of group A streptococcal infections |
| US6264945B1 (en) | 1997-10-31 | 2001-07-24 | Vincent A Fischetti | Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| US20060292135A1 (en)* | 1997-10-31 | 2006-12-28 | Lawrence Loomis | Use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl |
| US6254866B1 (en) | 1997-10-31 | 2001-07-03 | New Horizons Diagnostics Corporation | Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract |
| US6248324B1 (en) | 1997-10-31 | 2001-06-19 | Vincent Fischetti | Bacterial phage associated lysing enzymes for treating dermatological infections |
| CN1352567A (en)* | 1999-02-25 | 2002-06-05 | 新眼界诊断公司 | A means for the prophylactic and therapeutic treamtent of streptococcal infections |
| IN2001DE00791A (en) | 1999-02-25 | 2007-05-25 | New Horizons Diagnostics Inc | |
| US6056955A (en) | 1999-09-14 | 2000-05-02 | Fischetti; Vincent | Topical treatment of streptococcal infections |
| EP1501925A4 (en) | 2002-05-17 | 2006-10-25 | New Horizons Diagnostics Corp | IDENTIFICATION OF A PHAGEN-ASSOCIATED LYTICAL ENZYME FOR THE FAST AND SPECIFIC DETECTION AND BUTTERFLY OF BACILLUS ANTHRACIS |
| US8326388B2 (en) | 2002-10-31 | 2012-12-04 | Toshiba Medical Systems Corporation | Method and apparatus for non-invasive measurement of living body characteristics by photoacoustics |
| WO2004043376A2 (en)* | 2002-11-07 | 2004-05-27 | Synergy America, Inc. | Compositions and methods for treating or preventing pneumococcal infection |
| WO2004104213A2 (en) | 2003-05-15 | 2004-12-02 | The Rockefeller University | Nucleic acids and polypeptides of c1 bacteriophage and uses thereof |
| US7569223B2 (en) | 2004-03-22 | 2009-08-04 | The Rockefeller University | Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions |
| WO2005089527A2 (en) | 2004-03-24 | 2005-09-29 | The Rockefeller University | Lytic enzymes and spore surface antigen for detection and treatment of bacillus anthracis bacteria and spores |
| GB0410220D0 (en)* | 2004-05-07 | 2004-06-09 | Kirkham Lea Ann | Mutant pneumolysin proteins |
| US8389469B2 (en) | 2005-06-06 | 2013-03-05 | The Rockefeller University | Bacteriophage lysins for Bacillus anthracis |
| US7582291B2 (en)* | 2005-06-30 | 2009-09-01 | The Rockefeller University | Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria |
| DE602006018746D1 (en)* | 2005-08-24 | 2011-01-20 | Univ Rockefeller | PLY-GBS MUTANT LYSINE |
| IE20060488A1 (en)* | 2006-06-29 | 2008-01-09 | Teagasc Agric Food Dev Authori | Recombinant staphylococcal phage lysin as an antibacterial agent |
| DE102006061002A1 (en)* | 2006-12-22 | 2008-06-26 | Profos Ag | Method and means for enrichment, removal and detection of gram-positive bacteria |
| CA2706600A1 (en) | 2007-11-26 | 2009-06-04 | Plant Bioscience Limited | Novel polypeptides having endolysin activity and uses thereof |
| EP2103308A1 (en)* | 2008-03-20 | 2009-09-23 | PhytoLine GmbH | Method for producing a mixture of bacteriophages and its use in therapy of antibiotic-resistant staphylococci |
| EP3263588A1 (en) | 2008-07-03 | 2018-01-03 | The Rockefeller University | Isolated staphylococcus-specific soluble binding molecule |
| CA2736062A1 (en)* | 2008-07-24 | 2010-01-28 | The United State Of America, As Represented By The Secretary Of Agricuure | Triple acting antimicrobials that are refractory to resistance development |
| GB0815484D0 (en)* | 2008-08-26 | 2008-10-01 | Univ Leuven Kath | Antibacterial agents |
| KR101016918B1 (en)* | 2009-01-08 | 2011-02-25 | 주식회사 인트론바이오테크놀로지 | Novel Lysine Proteins with Bacteria Specific Wide Antibacterial Activity |
| CN103080307A (en)* | 2010-01-25 | 2013-05-01 | 美艾利尔斯卡保罗有限公司 | A25 bacteriophage lysin |
| JP2014519485A (en)* | 2011-04-21 | 2014-08-14 | ユニベルシタイト ユトレヒト ホールディング ベーフェー | Streptococcus bacteriophage lysine for treating gram positive bacteria in companion animals and livestock |
| Publication | Publication Date | Title |
|---|---|---|
| MX2021007008A (en) | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria. | |
| IL274832A (en) | Bacteriophage lysin and antibiotic combinations against gram positive bacteria | |
| WO2013122888A3 (en) | Methods of treating bacterial infections | |
| BR112012033212A2 (en) | use of lactobacillo inhibiting isolated coliform bacteria gas production in colic-affected infants | |
| WO2014018596A3 (en) | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides | |
| WO2013184755A3 (en) | Seca inhibitors and methods of making and using thereof | |
| GB201013307D0 (en) | Anti-microbial metal organic framework | |
| SG11201405829WA (en) | Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections | |
| MX346664B (en) | A composition comprising an antibiotic and a dispersant or an anti -adhesive agent. | |
| WO2013036783A3 (en) | Methods for treating intrapulmonary infections | |
| PH12014502680A1 (en) | Polysaccharide compositions and methods of use | |
| AU2012335397A8 (en) | Novel bacteriophages | |
| PH12015501131A1 (en) | Fibrinolytic compositions comprising bromelain and nattokinase for the prevention and treatment of phlebothrombotic states | |
| WO2012141540A3 (en) | Novel isolated lactobacillus fermentum strain having viral infection inhibitory activity | |
| HK1206594A1 (en) | Materials and methods for prevention and treatment of viral infections | |
| WO2013009678A3 (en) | Compositions and methods for the treatment of norovirus infection | |
| WO2013155320A3 (en) | Use of microbial gene products to prevent or treat microbial infections | |
| WO2015063608A3 (en) | Prevention and dispersion of biolfilm | |
| HK40090815A (en) | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria | |
| PL392681A1 (en) | New strains of bacteriophages for treating bacterial infections, especially of drug-resistant Klebsiella strains | |
| IN2014KN02584A (en) | ||
| MX2013012603A (en) | Liposomal vancomycin for the treatment of mrsa infections. | |
| MY171941A (en) | Pharmaceutical compositions |